Amgen Inc. (AMGN)

Overview Products Trials

Market Cap	$148.22B
Revenue TTM
Earnings Date	2025-02-04
Website	https://www.amgen.com

Upcoming PDUFA Dates

No upcoming PDUFAs found

Upcoming Trial Readouts

Feature coming soon

Upcoming Patent Expirations

Brand Name	Patent Number	Expire Date
CORLANOR	7361649	2/22/2026
CORLANOR	7361650	2/22/2026
CORLANOR	7879842	2/22/2026
CORLANOR	7361649	2/22/2026
CORLANOR	7361650	2/22/2026
CORLANOR	7879842	2/22/2026
KYPROLIS	7417042	7/20/2026
CORLANOR	7361649*PED	8/22/2026
CORLANOR	7361650*PED	8/22/2026
CORLANOR	7879842*PED	8/22/2026
SENSIPAR	7829595	9/22/2026
SENSIPAR	9375405	9/22/2026
Prolia	8,247,210	12/6/2026
Prolia	8,460,896	12/6/2026
Prolia	8,680,248	12/6/2026
Xgeva	8,247,210	12/6/2026
Xgeva	8,460,896	12/6/2026
Xgeva	8,680,248	12/6/2026
CORLANOR	7867996	12/12/2026
CORLANOR	7867996	12/12/2026
Prolia	7,928,205	2/12/2027
Xgeva	7,928,205	2/12/2027
Prolia	7,888,101	4/6/2027
Xgeva	7,888,101	4/6/2027
Prolia	7,662,930	4/24/2027
Xgeva	7,662,930	4/24/2027
Prolia	9,359,435	5/22/2027
Xgeva	9,359,435	5/22/2027
CORLANOR	7867996*PED	6/12/2027
KYPROLIS	7737112	12/7/2027
OTEZLA	7427638	2/16/2028
OTEZLA	7427638*PED	8/16/2028
KYPROLIS	RE47954	10/21/2029
Prolia	8,053,236	1/19/2030
Prolia	9,228,168	1/19/2030
Xgeva	8,053,236	1/19/2030
Xgeva	9,228,168	1/19/2030
Neulasta	9,856,287	6/21/2030
Neulasta Onpro	9,856,287	6/21/2030
PARSABIV	8377880	7/29/2030
PARSABIV	9278995	7/29/2030
PARSABIV	9701712	7/29/2030
Prolia	9,320,816	11/14/2030
Xgeva	9,320,816	11/14/2030
PARSABIV	8999932	2/7/2031
Prolia	9,012,178	8/5/2031
Xgeva	9,012,178	8/5/2031
Prolia	9,133,493	4/20/2032
Prolia	9,388,447	4/20/2032
Xgeva	9,133,493	4/20/2032
Xgeva	9,388,447	4/20/2032
Prolia	11,292,829	6/29/2032
Prolia	11,634,476	6/29/2032
Prolia	11,685,772	6/29/2032
Xgeva	11,292,829	6/29/2032
Xgeva	11,634,476	6/29/2032
Xgeva	11,685,772	6/29/2032
KYPROLIS	9493582	2/27/2033
Prolia	11,486,883	3/26/2033
Xgeva	11,486,883	3/26/2033
Prolia	9,328,134	2/20/2034
Xgeva	9,328,134	2/20/2034
Prolia	11,319,568	3/10/2034
Prolia	11,459,595	3/10/2034
Prolia	11,952,605	3/10/2034
Prolia	12,084,686	3/10/2034
Xgeva	11,319,568	3/10/2034
Xgeva	11,459,595	3/10/2034
Xgeva	11,952,605	3/10/2034
Xgeva	12,084,686	3/10/2034
Prolia	10,421,987	5/29/2034
Prolia	10,894,972	5/29/2034
Prolia	11,434,514	5/29/2034
Prolia	11,946,085	5/29/2034
Prolia	9,481,901	5/29/2034
Xgeva	10,421,987	5/29/2034
Xgeva	10,894,972	5/29/2034
Xgeva	11,434,514	5/29/2034
Xgeva	11,946,085	5/29/2034
Xgeva	9,481,901	5/29/2034
OTEZLA	10092541	5/29/2034
OTEZLA	9872854	5/29/2034
PARSABIV	10344765	6/27/2034
PARSABIV	11162500	6/27/2034
PARSABIV	11959486	6/27/2034
PARSABIV	9820938	6/27/2034
Prolia	11,299,760	10/30/2034
Xgeva	11,299,760	10/30/2034
OTEZLA	10092541*PED	11/29/2034
OTEZLA	9872854*PED	11/29/2034
Prolia	10,513,723	12/9/2034
Prolia	11,254,963	12/9/2034
Xgeva	10,513,723	12/9/2034
Xgeva	11,254,963	12/9/2034
Prolia	10,106,829	12/11/2034
Prolia	10,227,627	12/11/2034
Prolia	10,655,156	12/11/2034
Prolia	10,907,186	12/11/2034
Xgeva	10,106,829	12/11/2034
Xgeva	10,227,627	12/11/2034
Xgeva	10,655,156	12/11/2034
Xgeva	10,907,186	12/11/2034
Prolia	11,130,980	4/5/2035
Xgeva	11,130,980	4/5/2035
Prolia	11,077,404	5/13/2035
Xgeva	11,077,404	5/13/2035
Prolia	11,384,378	6/4/2035
Prolia	11,427,848	6/4/2035
Xgeva	11,384,378	6/4/2035
Xgeva	11,427,848	6/4/2035
Prolia	10,583,397	7/28/2035
Xgeva	10,583,397	7/28/2035
Prolia	11,786,866	10/21/2035
Xgeva	11,786,866	10/21/2035
Prolia	10,167,492	12/1/2035
Prolia	10,822,630	12/1/2035
Xgeva	10,167,492	12/1/2035
Xgeva	10,822,630	12/1/2035
Prolia	11,275,090	7/2/2037
Xgeva	11,275,090	7/2/2037
Prolia	11,098,079	7/21/2037
Xgeva	11,098,079	7/21/2037
LUMAKRAS	10519146	5/21/2038
Prolia	11,744,950	11/21/2039
Xgeva	11,744,950	11/21/2039
LUMAKRAS	11236091	5/20/2040
LUMAKRAS	11827635	5/20/2040
LUMAKRAS	11426404	9/15/2040